We are live on ! Find out more
IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

Back to rankings

23 hedge funds and large institutions have $17.4M invested in Intermolecular, Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $17.9M → $17.4M (-$516K)

8% less funds holding

Funds holding: 25 → 23 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$7.42K
2
TRCT
Tower Research Capital (TRC)
New York
+$6.18K
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.84K
4
Morgan Stanley
Morgan Stanley
New York
+$184

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$127K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$78K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$67.5K
4
BlackRock
BlackRock
New York
-$40.2K
5
Citadel Advisors
Citadel Advisors
Florida
-$26K

IMI Hedge Fund Activity: Q2 2017 in Review

23 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q2 2017, worth a combined $17.4M — down 2.9% from $17.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMI and 2 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, opening a new position worth an estimated $7.42K. The largest seller was Bridgeway Capital Management, cutting an estimated $127K.

  • 23 institutional investors held Intermolecular, Inc. (IMI) as of Q2 2017, down from 25 in Q1 2017.
  • Funds reported $17.4M of Intermolecular, Inc. stock for Q2 2017, down 2.9% quarter-over-quarter.
  • 2 funds opened new Intermolecular, Inc. positions in Q2 2017 and 4 closed out, a net change of -2 holders.
  • The largest Intermolecular, Inc. buyer in Q2 2017 was UBS Group, an estimated $7.42K added.
  • The largest Intermolecular, Inc. seller in Q2 2017 was Bridgeway Capital Management, an estimated $127K sold.

Based on aggregated 13F filings for Q2 2017.